• The News & Observer (Raleigh, N.C.) reported on the partnership between the School, the School of Medicine, and the Hamner Institutes to establish a drug-safety center in RTP.
  
• Howard McLeod, PharmD, was interviewed for a WRAL story on a UNC clinical trial that used genetic screening to predict the appropriate dosage of tamoxifen for breast cancer patients.
• The Herald-Sun (Durham, N.C.) briefly covered the $1.5 million National Cancer Institute grant awarded to Moo Cho, PhD.
  
• The Herald-Sun (Durham, N.C.) interviewed Stephen Frye, PhD, who directs the Center for Integrative Chemical Biology and Drug Discovery, in an August 9, 2008, story about UNC's new Genetic Medicine Building. Frye's center will occupy part of the School of Pharmacy's space in the new building.
• Alex Tropsha, PhD, was quoted extensively in August 2008 Nature Reviews Drug Discovery (vol. 7, no. 8) article on cheminformatics.
• Stephen Frye,PhD, was interview for a July Nature article on the challenges facing pharmaceutical companies, specifically GlaxoSmithKline.
• Health bloggers at the Wall Street Journal, New York Times and the Los Angeles Times on July 10, 2008, wrote about a paper by Sue Blalock, Stefanie Ferreri, and Mary Roth McClurg that listed the prescription drugs most likely to contribute to an increased risk of falling for adults aged sixty-five and older.
• Phil Rodgers, PharmD, commented on the safety of the drugs Advair, Ketek, Prilosec, Nexium, and pseudoephedrine in a Men's Health article titled "Drugs Doctors Would Never Take" that was published in the magazine and on MSN.com.
• WRAL.com and the Raleigh News & Observer reported on the May 21, 2008, renaming of the School in honor of alumnus Fred Eshelman.
• The Associated Press interviewed Howard McLeod for a May 5, 2008, article about the reliability and usefulness of genetic tests to determine a person's risk for developing a particular disease.
• U.S. News & World Report on March 28, 2008, ranked the School's PharmD program second in the country.
• An article in Biotech360 profiled Bryan Roth's research in receptoromics, the massively parallel screening of drug compounds against a wide spectrum of receptors.
• Stephen Frye was interviewed for a March 26, 2008, article in the News & Observer about new drug discovery centers at UNC-Chapel Hill and Duke University. Frye is the director of the Center for Integrative Chemical Biology and Drug Discovery at UNC.
• Jian Liu was interviewed for a March 22, 2008, article in the Chicago Tribune about the growing attention on the search for a synthetic form of heparin.
• Professor Tony Hickey was interviewed by WUNC radio and the News & Observer about the trials his lab ran on a new inhaled BCG tuberculosis vaccine provided by Harvard University. The story appeared in a number of newspapers, including The Charlotte Observer and the Kansas City Star and by in-Pharma Technologist. Research Assistant Professor Lucila Garcia-Contreras, a member of the UNC team that worked on the vaccine, was interviewed for a BBC Mundo story on the subject.
• Stefanie Ferreri was interviewed for a story in the March 9, 2008, edition of the News & Record about Thomasville pharmacist Amy Greeson, a School alumna, and her project to study and document alternative forms of medicine.
• Jian Liu was interviewed for a front-page story in the February 28, 2008, edition of the New York Times, about problems with the heparin supply chain in China. Liu also discussed the issue on CNN during a segment of the February 29 edition of Lou Dobbs Tonight. Liu was also cited in a March 20, 2008, article in The Wall Street Journal and a March 26, 2008, article in The Globe and Mail (Toronto).
• A February 21, 2008, story by MedPage Today reported on a study led by Betsy Sleath, which found that rheumatologists need to do a better job identifying the symptoms of depression in their patients.
• Both the News & Observer and the Wilmington Star-News published stories in February 2008 on Fred Eshelman's $1 million gift and a $1 million match from the Pharmacy Network Foundation to support the School's Educational Renaissance initiatives.
• January 24, 2008, stories by the News & Observer and WRAL about the University's Carolina First campaign reported on a $9 million gift to the School from Fred Eshelman, CEO and founder of Wilmington-based PPD Inc.
• The January 4, 2008, edition of the Triangle Business Journal profiled the Genetic Medicine Building, which will house laboratories, classrooms, and offices for the School of Pharmacy and School of Medicine upon its completion in spring 2008. Bob Blouin, the dean of the School of Pharmacy, was interviewed in the article.

2007

• Xiao Xiao, the Fred Eshelman Distinguished Professor of Gene Therapy in the Division of Molecular Pharmaceutics, was interviewed in a November 16, 2007, story in the Triangle Business Journal about a new drug delivery system discovered by two North Carolina State professors. Xiao provided an evaluation of the new technology, which is based on a hardy plant virus.
• A $26.5 million venture capital commitment to Oriel Therapeutics, a dry-powder inhaler company cofounded by School professor Anthony Hickey, PhD, was reported in November 16, 2007, articles by the News & Observer and the Triangle Business Journal.
• Howard McLeod was interviewed in a November 2, 2007, article in the Triangle Business Journal about the development of a saliva test by Paragon Dx for determining whether a drug is safe for patients.
• Professor Howard McLeod's study on the effect of gene variations on irinotecan toxicity was cited in a story in the October 2007 issue of Nature Reviews Drug Discovery about the anticoagulant warfarin.
• In a September 28, 2007, article, the Triangle Business Journal reported on the new Center for Integrative Chemical Biology and Drug Discovery, which is spearheaded by the School of Pharmacy in partnership with UNC's Department of Chemistry, School of Medicine, and Lineberger Comprehensive Cancer Center. Dean Bob Blouin, Professor Alex Tropsha, and center director Stephen Frye were interviewed for the story.
• Bryan Roth, a professor in the Division of Medicinal Chemistry and Natural Products, was interviewed in a story by The Early Show on CBS about the hallucinogenic herb salvia divinorum on September 25, 2007.
• Dean Bob Blouin was interview for a September 24, 2007, Greensboro News & Record article on the shortage of pharmacists in North Carolina.
• Scott Singleton was quoted in two September 6, 2007, articles in The Scientist and in Nature discussing the mechanism by which antibiotics kill bacteria. He also was quoted in a September 10, 2007, article in Chemical & Engineering News on the same subject. Singleton is an associate professor in the Division of Medicinal Chemistry studying methods of overcoming drug resistance in bacteria.
• In an August 3, 2007, article, the Triangle Business Journal recognizes the School of Pharmacy's dramatic increase in NIH funding.
• In a July 26, 2007, article on the health and fitness Web site Homemakers.com, Professor Fred Eckel offered advice on how consumers should decide between brand or generic cold medication.
• Associate Professor Scott Singleton was quoted in a July 10, 2007, story in the Raleigh News & Observer about the discovery of two new weapons in the fight against antibiotic-resistant bacteria.
• Eshelman Professor Howard McLeod was interviewed for a June 12, 2007, story in the Orlando Sentinel on the Pharmacogenetics for Every Nation Initiative.
• The Scientist interviewed Professor Bryan Roth for a June 2007 story about the drug potential of an active ingredient in Salvia divinorum, a hallucinogenic mint first used by Mexican shamans for spiritual journeys.
• Associate Professor Betsy Sleath's survey showing that North Carolina physicians do not often screen do not often screen new mothers for postpartum depression received significant state coverage. The study appears in the June 6, 2007, North Carolina Medical Journal. WRAL Newswise News & Observer   
• Ferguson Distinguished Professor Mick Murray's study in the May 15, 2007, Annals of Internal Medicine showing how a pharmacist's support of heart-failure patients can reduce health-care costs received national and internation coverage. UPI ASHP Medpage Today 
• United Press Internation interviewed Eshelman Distinguished Professor Howard McLeod for a story on the need for more racial and ethnic diversity among subjects in clinical trials.
• The journal Science interviewed Scott Singleton, an associate professor in the Division of Medicinal Chemistry and Natural Products, in a March 28, 2007, story about the discovery of compounds that fight bacterial resistance to antibiotics. Singleton chaired the national meeting of the American Chemical Society where the discovery was announced.
• The Raleigh News & Observer described the kind of research done by the UNC Institute for Pharmacogenomics and Individualized Therapy, headed by Howard McLeod, as promising "the right dose of the right drug for the right patient at the right time" in a April 12 story on personalized medicine.
• Clinical Assistant Professor Stefanie Ferreri was interviewed by WRAL News for an April 5 report on Medicare Part D's gap in coverage, or "doughnut hole."
• Clinical Assistant Professor Stefanie Ferreri and Clinical Instructor Jena Ivey appeared in an NBC news feature on Wal-mart's four-dollar generic-prescription program. The program aired February 21 on Raleigh's WNCN NBC-17 and will be distributed to NBC affiliates nationwide.
• Bryan Roth, a professor in the Division of Medicinal Chemistry and Natural Products and in the Department of Pharmacology, has been quoted in the New York Times and other publications for a perspectives piece he wrote for the January 4, 2007, issue of the New England Journal of Medicine. Roth analyzes studies that identifies problems with two drugs used to treat Parkinson's disease. He recommends no longer prescribing either drug. He was also interviewed on National Public Radio. Click here to listen. (January 4, 2007) For links to more coverage, click here.
• Clinical Assistant Professor Stefanie Ferreri was interviewed by NBC about acetaminophen, which appeared on several local and national newscasts. (January 25, 2006)

•  HIV drug in “HIV drug created at UNC generates buzz.” (September 9, 2005)